CD8+ T cells are predominantly cytotoxic and play a crucial role in eliminating tumor cells; however, their functionality can be compromised by immune checkpoint molecules, such as PD-1, which is frequently upregulated in DLBCL [26,28]. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.